Search Within

Emanuela Ferraro

Formats
  1. Meeting Abstract (14)
  2. Journal Article (10)
  3. Review (7)
  4. Editorial (1)
Groups
  1. Breast Medicine Service (26)
  2. Department of Medicine (26)
  3. Solid Tumor Oncology Division (26)
  4. Survivorship Research (15)
  5. GSK Faculty (12)
  6. Human Oncology and Pathogenesis Program (12)

More Groups

People
  1. Pedram Razavi (12)
  2. Mark Robson (11)
  3. Sarat Chandarlapaty (11)
  4. Shanu Modi (11)
  5. Andrew Seidman (9)
  6. Chau Dang (9)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (7)
  4. 2022 (8)
  5. 2021 (4)
  6. 2020 (3)
Publications
  1. Journal of Clinical Oncology (11)
  2. Cancer Treatment and Research (3)
  3. Annals of Oncology (2)
  4. Cancer Treatment Reviews (2)
  5. European Journal of Cancer (2)
  6. npj Breast Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Elsevier Inc. (5)
  3. Springer (4)
  4. Nature Publishing Group (3)
  5. Oxford University Press (2)
  6. AME Publishing Company (1)

More Publishers

Results (32)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequential antibody-drug conjugate therapy in patients with metastatic breast cancer treated with sacituzumab govitecan and trastuzumab deruxtecan
    Journal Article

    Mai, N.; Lieberman, M. M. K.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Survival among patients with ERBB2-positive metastatic breast cancer and central nervous system disease
    Journal Article

    Ferraro, E.; Reiner, A. S.; Bou Nassif, R.; Tosi, U.; Brown, S.; Zeller, S.; Dang, C. T.; Seidman, A. D.; Moss, N. S.
    JAMA Network Open (2025)

    Fulltext@MSK | Save
  • Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Chew, S. M.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D.; Modi, S.; Seidman, A. D.; Wen, H.; Brogi, E.; Robson, M.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan
    Meeting Abstract

    Mai, N.; Klar, M.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Personalized circulating tumor DNA for minimal residual disease and dynamic assessment in patients undergoing neoadjuvant chemotherapy for breast cancer: Preliminary analysis from MSK-LINC
    Meeting Abstract

    Kim, H. K.; An, J. A. R.; Smith, C. G.; Kim, J.; Cabel, L.; Moiso, E.; Ferraro, E.; Safonov, A.; Nelson, K.; Szuhany, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Overall survival analysis of first line CDK4/6 inhibitors in a large real-world cohort of patients with hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer
    Meeting Abstract

    Ferraro, E.; Moiso, E.; Safonov, A.; Cabel, L.; Loudon, L.; Dang, C. T.; Shen, S.; Jhaveri, K. L.; Robson, M. E.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Predicting CDK4/6 inhibitors outcomes in pts with HR+/HER2-metastatic breast cancer: A machine learning approach
    Meeting Abstract

    Moiso, E.; Ferraro, E.; Cabel, L.; Safonov, A.; Ahmed, M.; An, J. A. R.; Jhaveri, K. L.; Norton, L.; Robson, M. E.; Modi, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Genomic biomarkers of CNS-specific outcomes in patients with breast cancer brain metastases
    Meeting Abstract

    Khatri, I. S.; Eichholz, J.; Boe, L. A.; Safonov, A.; Smith, D. R.; Ferraro, E.; Shen, J.; Imber, B. S.; Yu, Y.; Yamada, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials
    Journal Article

    Nicolò€, E.; Gandini, S.; Giugliano, F.; Uliano, J.; D'Ecclesiis, O.; Morganti, S.; Ferraro, E.; Trapani, D.; Tarantino, P.; Zagami, P.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Impact of cyclin dependent kinase 4/6 inhibitors on breast cancer brain metastasis outcomes
    Journal Article

    Chew, S. M.; Ferraro, E.; Safonov, A.; Chen, Y.; Kelly, D.; Razavi, P.; Robson, M.; Seidman, A. D.
    European Journal of Cancer (2024)

    Fulltext@MSK | Save